The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Kailash Shantilal Choudhari & PACs
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre Ltd, has disclosed a sale of 40,967 equity shares (0.03% of paid-up capital) on December 04, 2025 through the open market under Regulation 29(2) of SEBI (SAST) Regulations, 2011. His individual holding reduced from 45,03,892 shares (2.77%) to 44,62,925 shares (2.74%). Together with Persons Acting in Concert (Rohan Rashi Family Trust, Mrs. Mona Kailash Choudhari, Mr. Rohan Kailash Choudhari, and Ms. Rashi Choudhari), the promoter group holds 1,37,63,925 shares, approximately 8.46% of the company. The mode of sale is open market and the equity share capital remains unchanged at 16,26,97,971 shares of Rs. 5 each.
This is a small, routine trim by the promoter (only 0.03% reduction) and is unlikely to materially affect the stock price. It signals minor diversification by the promoter but no meaningful change in control or promoter group strength.